Treatment of primary syphilis

Area of Science:

• Infectious Diseases
• Bacteriology
• Pharmacology

Background:

• Syphilis, a sexually transmitted infection caused by *Treponema pallidum*, remains a significant global health concern.
• Effective antibiotic treatment is crucial for managing primary syphilis and preventing disease progression.
• Benzathine penicillin is a primary treatment, but data on other regimens are limited.

Purpose of the Study:

• To review English-language reports on the treatment of primary syphilis.
• To evaluate the documented efficacy of currently recommended dosage schedules for primary syphilis.
• To identify areas requiring further investigation regarding syphilis treatment protocols.

Main Methods:

• Systematic review of published English-language studies on primary syphilis treatment.
• Analysis of efficacy data for various antibiotic regimens and dosage schedules.
• Identification of knowledge gaps and recommendations for future research.

Main Results:

• Efficacy data for primary syphilis treatment are primarily documented by Schroeter et al. for regimens other than benzathine penicillin.
• Generally acceptable failure rates were reported by Schroeter et al. for the evaluated schedules.
• Limited evidence exists to compare the efficacy of different treatment regimens.

Conclusions:

• Further studies are essential to determine if efficacy differences exist among various syphilis treatment regimens.
• Additional research is needed to ascertain if current syphilis treatment schedules are equally effective for both primary and secondary syphilis.
• The impact of increased dosages on reducing syphilis treatment failure rates requires further investigation.